Guide · Checked September 27, 2026
The story to bring to a first ED appointment
Describe what changed, the health context and the medicines involved without having to diagnose yourself before the conversation.
Editorial document research · How we use sources
You do not need a polished explanation for erectile difficulties before speaking with a clinician. A simple account of what has changed can be more useful than selecting a cause from an advertisement. There may be several concerns to discuss: getting an erection, maintaining it, changes in desire, discomfort or worry about the experience. They need not all have the same explanation.
A Private Consultation is an educational publication, not a medical practice or a confidential clinical intake service. This guide helps organize questions for an actual appointment; it does not ask you to submit personal health details here. The aim is to bring enough context for the clinician to assess the concern, while leaving diagnosis and treatment decisions to the professionals providing care.
In this article
Keep this question in view
A clear history helps a clinician investigate the problem. It does not replace an examination, relevant tests or a decision about the actual medicine.
Start with a description rather than a label
NIDDK's diagnosis resource describes a medical, sexual and mental-health history as part of ED evaluation. Tell the clinician what you have noticed, whether the change is recent or longstanding, and how it affects you. A concern about maintaining an erection is different from reduced interest in sex, even when both are present. Plain language is enough.
It can help to explain whether the difficulty is consistent or varies with circumstances, without assuming that variation proves a psychological or physical cause. The EAU guideline discusses mixed causes and different dimensions of sexual function. A history gives the clinician information to interpret; it is not a scoring exercise that guarantees a particular prescription.
Bring the wider health story into the conversation
Past surgery, injuries, long-term conditions and changes in health may be relevant even when they seem separate from sexual function. NIDDK identifies potential contributions from blood vessels, nerves, hormones, medicines and emotional factors. Mention significant changes rather than deciding in advance which ones deserve to count as the cause.
Prior test reports and the names of existing clinicians can help establish what has already been assessed. They should not be reduced to a single reassuring number detached from its date or context. Our cardiovascular assessment guide explains why heart-health questions may belong in an ED visit without implying that erectile difficulty diagnoses a heart condition.
Use an actual medicine list, including occasional items
A list should distinguish current prescriptions from products used only sometimes, along with nonprescription medicines and supplements. Names from the package or pharmacy record are more useful than descriptions such as a heart pill or a small white tablet. NIDDK's diagnostic guidance specifically includes prescribed and over-the-counter products, vitamins and supplements in the history.
The sildenafil label identifies important interaction concerns, including nitrates and riociguat. Our medicine-review guide explains why intermittent use also matters. Do not omit a medicine to simplify an intake or change it to make an advertised product seem suitable. The prescribing team needs an accurate account, including uncertainties you want the pharmacist to help resolve.
Make room for emotional and relationship context
Stress, anxiety and relationship concerns can affect sexual health without making the experience less real. NIDDK's treatment guidance includes counseling when mental-health or emotional issues contribute. Discussing those concerns does not mean every physical explanation has been excluded or that a medicine is necessarily the next step.
You can ask why a sensitive question is relevant and what information would help the assessment. A partner's observations may be useful when you want them involved, but the clinician still needs your account of symptoms and goals. The purpose is an understandable conversation, not a demand to fit a performance ideal or disclose intimate details to an unrelated review site.
Ask what an online visit can establish and what remains
Both NIDDK and the EAU describe physical examination and relevant testing within ED assessment. Completing a questionnaire is one way to provide information; it does not establish that every necessary part of an evaluation has occurred. Ask how the clinician will decide whether records, an examination, tests or another professional's input are needed.
The care-pathways comparison separates published service arrangements from proof of an adequate individual assessment. An existing primary-care clinician or urologist may hold relevant information. If care is shared, identify who will explain findings and how records will reach them. This guide does not prescribe a test panel or determine which appointment format is appropriate for you.
Identify the proposed medicine before discussing expectations
CoreAge's 4Play page describes a compounded preparation containing apomorphine and three PDE5 inhibitors. Our CoreAge assessment review examines that advertised pathway. A familiar ingredient or a brief online process cannot establish that the full formula is appropriate for someone whose history has not been assessed.
The sildenafil label says combinations with other PDE5 inhibitors or ED therapies have not been studied, can further lower blood pressure and are not recommended. FDA also distinguishes compounded finished products from approved medicines. If a combination is proposed, the clinician should address those limitations directly. The appointment is an opportunity to understand the rationale, alternatives and unanswered questions.
Leave knowing who will explain the next step
Ask what has been established, what is still being investigated and who will communicate any results. If treatment is prescribed, the follow-up guide explains what information can help a later review of benefit and unwanted effects. A completed visit or medication delivery does not settle every continuing care responsibility.
This publication participates in the CoreAge Rx promotional publishing network, with its first commercial listing openly disclosed. That relationship does not validate a diagnosis, guarantee a prescription or supply independent clinical endorsement. The practical goal is a clear account of your concern and a professional explanation of the assessment, with enough room for questions rather than pressure to arrive at a predetermined product.
Source documents
Provider documents establish what is advertised. Clinical and regulatory documents have different roles and do not independently verify the provider’s actual care.
- NIDDK: Diagnosis of Erectile Dysfunction, reviewed October 2024Government clinical information · Checked 2026-09-27
- European Association of Urology: Management of Erectile DysfunctionSpecialty society clinical guideline · Checked 2026-09-27
- NIDDK: Symptoms and Causes of Erectile Dysfunction, reviewed October 2024Government clinical information · Checked 2026-09-27
- DailyMed: Advagen sildenafil tablets, updated January 7, 2026Exact product prescribing information · Checked 2026-09-27
- NIDDK: Treatment for Erectile Dysfunction, reviewed October 2024Government clinical information · Checked 2026-09-27
- CoreAge Rx: 4Play product descriptionProvider product description · Checked 2026-09-27
- FDA: Understanding the Risks of Compounded DrugsRegulatory explanation · Checked 2026-09-27